About: Use of lung ultrasound to differentiate COVID-19 pneumonia from community-acquired pneumonia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Use of lung ultrasound to differentiate COVID-19 pneumonia from community-acquired pneumonia Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Use of lung ultrasound to differentiate COVID-19 pneumonia from community-acquired pneumonia
Creator	Zhang, Ying Huang, Fang Zhao, Yanping Shen, Haolin, ; He, Shaozheng Lian, Xihua Lyu, Guorong Shen, Haolin Tan, Guoliang Wang, Xiali Wang, Zhenhua Zhu, Zhixing Zhang Bachelor, Ying Zhao Bachelor, Yanping
Source	Elsevier; Medline; PMC; WHO
abstract	To investigate the feasibility of lung ultrasound in evaluating coronavirus disease 2019 (COVID-19) and distinguish the sonographic features between COVID-19 and community-acquired pneumonia (CAP), a total of 12 COVID-19 patients and 20 CAP patients were selected and underwent the lung ultrasound. Modified Buda scoring system for interstitial lung disease (ILD) was used to evaluate the severity and treatment effect of COVID-19 on ultrasonography. The differences between modified lung ultrasound (MLUS) score and high-resolution computed tomography (HRCT) Warrick score were analyzed to evaluate their correlation. COVID-19 showed the following sonographic features: thickening (12/12), blurred (9/12), discontinuous (6/12) pleural line; rocket sign (4/12), partially diffused B-line (12/12), completely diffused B-line (10/12), waterfall sign (4/12); C-line sign (5/12); pleural effusion (1/12), and pulmonary balloon (Am line, 1/12). The last two features were rarely seen. Differences of ultrasonic features, including lesion range, lung signs and pneumonia-related complications, between COVID-19 and CAP were statistically significant (P<0.05 or 0.001). MLUS scores (P=0.006) and HRCT Warrick scores (P=0.015) increased as the severity of COVID-19 increased. The differences between moderate [29.00(25.75-37.50)] and severe [43.00(38.75-47.25)] (P=0.022) or between moderate and critical [47.50(44.25-50.00)] (P=0.002) type COVID-19 were statistically significant, compared with those between severe and critical types. Correlation between MLUS scores and HRCT Warrick scores was positive (r=0.54, P=0.048). MLUS scores (Z=2.61, P=0.009) and HRCT Warrick scores (Z=2.63, P=0.009) of five severe or critical COVID-19 patients significantly decreased as their conditions improved after treatment. The differences of sonographic features between COVID-19 and CAP patients were notable. The MLUS scoring system could be used to evaluate the severity and treatment effect of COVID-19.
has issue date	2020-06-05(xsd:dateTime)
bibo:doi	10.1016/j.ultrasmedbio.2020.05.006
bibo:pmid	32622684
has license	no-cc
sha1sum (hex)	1bc166839e4fbbaf874f888608c29dc0230cea83
schema:url	https://doi.org/10.1016/j.ultrasmedbio.2020.05.006
resource representing a document's title	Use of lung ultrasound to differentiate COVID-19 pneumonia from community-acquired pneumonia
has PubMed Central identifier	PMC7274602
has PubMed identifier	32622684
schema:publication	Ultrasound Med Biol
resource representing a document's body	covid:1bc166839e4fbbaf874f888608c29dc0230cea83#body_text
is schema:about of	named entity 'patients' named entity 'high-resolution computed tomography' named entity 'Warrick' named entity 'B-line' named entity 'patients' named entity 'sign' named entity 'scoring' named entity 'pulmonary' named entity 'MODIFIED' named entity 'WATERFALL' named entity 'COVID-19' named entity '0.001' named entity 'LINE' named entity 'SELECTED' named entity 'COMMUNITY-ACQUIRED PNEUMONIA' named entity 'COVID-19 PNEUMONIA' covid:arg/1bc166839e4fbbaf874f888608c29dc0230cea83 named entity 'partially' named entity 'blurred' named entity 'The' named entity 'balloon' named entity 'lung' named entity 'compared' named entity 'discontinuous' named entity 'COVID-19' named entity 'differences' named entity 'score' named entity 'Correlation' named entity 'severe' named entity 'thickening' named entity 'features' named entity 'community-acquired pneumonia' named entity 'ILD' named entity 'COVID' named entity 'HRCT' named entity 'high-resolution computed tomography' named entity 'pleural line' named entity 'interstitial lung disease' named entity 'lesion' named entity 'C-line' named entity 'COVID' named entity 'Correlation' named entity 'HRCT' named entity 'COVID' named entity 'CAP' named entity 'COVID' named entity 'ultrasound' named entity 'statistically significant' named entity 'lung' named entity 'community-acquired pneumonia' named entity 'lung' named entity 'early diagnosis' named entity 'sonographic' named entity 'COVID-19' named entity 'clinical application' named entity 'ultrasound' named entity 'nucleic acids' named entity 'ILD' named entity 'Buda' named entity 'Pneumonia' named entity 'moderate group' named entity 'alveoli' named entity 'monocytes' named entity 'lymphocytes' named entity 'COVID' named entity 'SARS' named entity 'gas phase'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software